Sm. Cockle et al., PEPTIDES RELATED TO THYROTROPIN-RELEASING-HORMONE (TRH) IN HUMAN PROSTATE AND SEMEN, Biochimica et biophysica acta. Molecular basis of disease, 1227(1-2), 1994, pp. 60-66
The TRH-related peptide, pGlu-Glu-ProNH(2), which was first identified
in rabbit prostate has recently been named fertilization-promoting pe
ptide (FPP) because of its ability to enhance the in vitro fertilizing
potential of mouse epididymal spermatozoa. This study set out to exam
ine the nature of the TRH-related peptides in human prostate and semen
but, first, the optimal conditions for collection of semen samples we
re investigated. FPP was degraded slowly (t(1/2) = 163 min, S.E. +/- 5
1.3, n = 6) in seminal plasma which has allowed us to measure accurate
ly the concentrations of FPP, after extraction of the peptide in acidi
fied acetone precisely 5 min after ejaculation. In this way, high leve
ls of FPP (mean: 49.5 nmol/l) were detected in normal human semen, fro
m young men, although other TRH-related peptides did not appear to be
present. We have also examined the TRH-related peptides present in pro
state samples from clinical patients both with and without evidence of
benign prostatic hyperplasia (BPH), by ion-exchange chromatography fo
llowed by radioimmunoassay. Substantial concentrations of FPP were obs
erved in normal (4.10 pmol/g tissue, S.E. +/- 1.46) and BPH prostate (
6.27 pmol/g tissue, S.E. +/- 1.65). In addition, a second, neutral TRH
-immunoreactive peptide was always detected in BPH tissue (7.40 pmol/g
tissue, S.E. +/- 1.98) with only low levels generally present in norm
al prostate. The possibility that the presence of high levels of the n
eutral peptide in prostate may be used as an indicator of the onset of
BPH deserves further scrutiny.